Aktis Oncology, Inc.(AKTS)Earnings Date, History & Expected Move

Next report date, beat rate and options-implied move

Next report

Not scheduled

AKTS has no upcoming report date in the calendar yet. It last reported on Aug 13, 2026; companies usually report every three months.

Next report

Not scheduled

Last reported Aug 13, 2026

EPS beat rate

25%

3 of 12 quarters

Avg move after earnings

±6.4%

Up 100% of the time · last 2

Options-implied move

—

No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 12 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±6.4%).

After an EPS beat

—

Not enough quarters yet

After an EPS miss

+6.4%

average next-day move · up 100% of 2 times

Why did AKTS rise after missing earnings?

2 of AKTS's last 2 reactions went against the EPS result. What stands out in each:

Rose despite an EPS miss (2 of 2)

Aug 13, 2026EPS missed -2.3%stock +4.8% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
May 11, 2026EPS missed -15.2%stock +8.0% next day
- It had already fallen 3.8% in the final week before the report, so weak results may have been expected.

Patterns in estimates and prices, not confirmed causes: how we read them.

AKTS earnings history

Last 12 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report date	Time	EPS est.	EPS actual	Surprise	1-day move	3-day move
Aug 13, 2026	After close	-$0.43	-$0.44	-2.3%	+4.79%	+5.09%
May 11, 2026	After close	-$0.33	-$0.38	-15.2%	+7.99%	+6.73%
Nov 14, 2024	Before open	-$0.08	-$0.04	+50.0%	—	—
Oct 8, 2024	Before open	-$0.14	-$0.75	-435.7%	—	—
May 13, 2024	Before open	-$0.12	-$0.14	-16.7%	—	—
Feb 13, 2024	Before open	-$0.18	-$0.19	-5.6%	—	—
Nov 13, 2023	Before open	-$0.18	-$0.27	-50.0%	—	—
Sep 6, 2023	Before open	-$0.18	-$0.21	-16.7%	—	—
May 8, 2023	Before open	-$0.21	-$0.20	+4.8%	—	—
Feb 7, 2023	Before open	-$0.25	-$0.19	+24.0%	—	—
Nov 14, 2022	Before open	-$0.23	-$0.28	-21.7%	—	—
Sep 12, 2022	Before open	-$0.21	-$0.26	-23.8%	—	—

AKTS Earnings FAQ

Answers computed from Aktis Oncology, Inc.'s reported history

AKTS has no upcoming report date in the calendar yet. It last reported on Aug 13, 2026; companies usually report every three months.

Over the last 12 quarters with a usable EPS surprise, AKTS beat the consensus estimate 3 times (25%), missed 9 and landed in line 0. It has missed estimates in each of the last 2 counted quarters.

Across its last 2 quarters with a measured reaction, AKTS moved an average of ±6.4% in the first session after reporting. It closed higher 100% of the time; the largest gain was 8.0% and the largest drop 4.8%.

How we calculate these numbers · AKTS: 12 reported quarters, latest Aug 13, 2026. Information only, not investment advice.

Earnings this week

Every report this week with expected moves.

Biggest expected earnings moves

Options-implied vs historical move, ranked.